Date: 20-Nov-2019

WuXi AppTec's lab testing division expands toxicology facility in Suzhou, China

WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries, announced its Lab Testing Division (LTD) has expanded the Suzhou safety assessment facility by increasing toxicology capacity by 80% to meet global customers' preclinical testing needs and enable them to accelerate the development timeliness and bring innovative medicines to patients faster. With the expansion, the toxicology facility will cover an area of 580,000 square feet and execute full-service preclinical and clinical stage safety assessments for biologic and small molecule drugs with the scientific expertise, technical experience and regulatory compliance required to adhere to the highest international quality standards.